← Leaderboards
Khalid Iqbal
Institute For Basic Res In Dev Disabil
$6,144,040
Attributed
$6,144,040
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $759.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,144,040 · 5
By mechanism
R01$5,318,765 · 2
R43$553,736 · 1
R03$271,539 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposTau ProteinsNeurofibrillary TanglesAbnormally Phosphorylated TauBrainLesionTauopathiesMouse ModelS DiseasePharmaceutical PreparationsLeadProteinsBaseProgramsMolecularGenerationsPhosphorylationDown SyndromeTau PhosphorylationProtein KinaseStagingAnimal ModelResearch PersonnelSelf Assembly
Grant awards (22)
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies$53,736
R43 · FY2023 · AG · contact PI
Treatment of Alzheimer's disease by clearing both tau and amyloid beta pathologies$500,000
R43 · FY2022 · AG · contact PI
I2PP2A: A Therapeutic Target$66,835
R03 · FY2013 · TW · contact PI
I2PP2A: A Therapeutic Target$70,352
R03 · FY2012 · TW · contact PI
Subgroups of Alzheimer Disease$320,870
R01 · FY2011 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$298,576
R01 · FY2011 · AG · contact PI
I2PP2A: A Therapeutic Target$70,352
R03 · FY2011 · TW · contact PI
Subgroups of Alzheimer Disease$329,751
R01 · FY2010 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$302,624
R01 · FY2010 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$430,357
R01 · FY2009 · AG · contact PI
Subgroups of Alzheimer Disease$329,088
R01 · FY2009 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$418,877
R01 · FY2008 · AG · contact PI
Subgroups of Alzheimer Disease$323,228
R01 · FY2008 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$416,053
R01 · FY2007 · AG · contact PI
Subgroups of Alzheimer Disease$328,009
R01 · FY2007 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$367,066
R01 · FY2006 · AG · contact PI
Abnormal Hyperphosphorylation of Tau$370,796
R01 · FY2005 · AG
Abnormal Hyperphosphorylation of Tau$365,867
R01 · FY2004 · AG
Abnormal Hyperphosphorylation of Tau$361,103
R01 · FY2003 · AG
Abnormal Hyperphosphorylation of Tau$356,500
R01 · FY2002 · AG
ALZHEIMER NEUROFIBRILLARY DEGENERATION$32,000
R03 · FY2001 · TW
ALZHEIMER NEUROFIBRILLARY DEGENERATION$32,000
R03 · FY2000 · TW